UK stem cell research 'at risk'

Plans to raise licensing fees 30-fold will stifle embryo research, scientists worry

Written byLinda Nordling
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The United Kingdom risks losing its world-leading position in human embryo research if suggestions for a 30-fold increase in license fees are taken forward, British researchers claimed this week.

The UK government's fertility watchdog, the Human Fertilisation and Embryology Authority (HFEA), is proposing to raise its fees for processing research project licenses from the present £200 (USD $367) to £6000 (USD $11,000). It claims the change is necessary to comply with government rules that regulation should be wholly paid for by those being regulated.

But UK researchers say that the increase is not well justified. They say that any attempt to increase fees will stifle research in emerging areas, such as stem cell research, and vital work on freezing and storing human embryos.

"We recognize that there are some administrative costs due in processing a license, but all our license applications will have already gone through local ethics committee approval ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies